openPR Logo
Press release

Global Next-generation Sequencing Market to 2022| Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech, Qiagen

02-11-2019 10:49 AM CET | Health & Medicine

Press release from: Next-generation Sequencing Market

Albany, NY, 11th February : Recent research and the current scenario as well as future market potential of "Next-generation Sequencing: Emerging Clinical Applications and Global Markets" globally.

Report Includes

An overview of the global market for next-generation sequencing and its emerging clinical applications.
Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.

Get PDF for more Professional and Technical insights @

Examination of the sequencing industry structure for key market segments.
Discussion covering the strategies employed by the main companies in the market.
Comprehensive company profiles of major players in the field.

Report Scope

The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS-based diagnostics are given for the years 2015, 2016, 2017 and 2022.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing. It then discusses some of the significant research initiatives that impact clinical NGS applications. The main market driving forces are also discussed.

The report examines the markets by test complexity, clinical indication and test purpose. Test complexity refers to the plex level (i.e., the number of genetic markers that can be analyzed within a sample) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics, etc.) will be in demand in the future.

The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, cardiovascular diseases, clinical microbiology and infectious diseases, Mendelian disorders, metabolic and immune disorders, neurological disorders, reproductive health, and transplant medicine.

View Complete TOC with tables & Figures @

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific, and the rest of the world.

Industry sectors analyzed include sequencing instruments, target enrichment, informatics, clinical laboratory testing services, reproductive health diagnostics, liquid biopsy, immune sequencing, HLA typing, third generation sequencing, and direct to consumer.

More than 200 companies in the clinical NGS industry are profiled in this report.

A summary of the main industry acquisitions and strategic alliances from 2015 through April 2017 are provided, including key alliance trends.

Table of Content

1: Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Geographic Breakdown

2: Summary and Highlights

Table 1 : Summary Table: Global Clinical Next-Generation Sequencing Market, by Disease Class, Through 2022
Figure 1 : Summary Figure: Global Clinical Next-Generation Sequencing Market, by Disease Class, 2015-2022

3: Overview

Clinical NGS Markets
Clinical NGS Growth Driving Forces
Clinical NGS Applications
Clinical NGS Industry

Make An Enquiry @

4: Technology Background

Importance of DNA
Genetic Variation and Analysis
Genetic Analysis Technologies
Sequencing in Clinical Applications
Sequencing Technologies

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Follow me on :

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Next-generation Sequencing Market to 2022| Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech, Qiagen here

News-ID: 1576080 • Views: 469

More Releases from Next-generation Sequencing Market

Global Next-generation Sequencing Market Trends, Regulations And Competitive Lan …
Albany, NY, 8th March : Recent research and the current scenario as well as future market potential of "Next-generation Sequencing: Emerging Clinical Applications and Global Markets" globally. The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in 2017 to $10.5 billion by 2022. Get Free PDF for more Professional and
Global Next-generation Sequencing Market is expected to grow at a compound annua …
ResearchMoz include new market research report "Next-generation Sequencing: Emerging Clinical Applications and Global Markets" to its huge collection of research reports. The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in 2017 to $10.5 billion by 2022. Non-cancer applications as a segment should reach $2.3 billion in 2017 to $6.4
Next-generation Sequencing Market – Global Industry Insights, Trends and Analy …
Growing prevalence of hereditary diseases and government initiatives will drive the overall next-generation sequencing market According to a report by Global Genes, in 2009, Europe accounted for around 30 million people of the 350 million people worldwide who suffered from some rare disease. Moreover, children accounted for around half the population affected by rare diseases. According to Net Wellness, more than 20% of the infant deaths are caused due to genetic
Next-generation Sequencing Market: Global industry analysis and forecast 2016-20 …
According to an article published in the magazine Scientific American, whole genome testing might not give accurate results all the time. A low risk disease might take a shape and affect the person in his lifetime. However, gene sequencing is helpful in predicting diseases and in most cases, preventing them. In the era of increased health awareness and advanced technologies, people around the world are embracing the early detection techniques

All 5 Releases

More Releases for NGS

NGS Sample Preparation Market Size - Forecasts to 2026
The NGS Sample Preparation Market will grow with a CAGR value of 19.20 percent. NGS is a technique for assessing the DNA/RNA sequence to analyses genetic diversity linked to disease or other biological phenomena. Advancements in NGS platforms and the declining cost of sequencing are supporting the market growth. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “NGS Sample Preparation Market - Forecast
NGS Data Analysis Market to Observe Strong Development by 2026
With continuous developments in cloud computing and data integration solutions, bottlenecks in data handling are being effectively addressed, which includes high throughput sequence data’s sizeable volume analysis. Introduction of NGS solutions coupled with rising clinical diagnosis requirement for personalized treatment of several ailments and genomic research, have created demand for precise and fasts sequencing and algorithms interpretation tools that can analyze data faster. Report overview @ This Fact.MR report analyzes
Next-generation Sequencing (NGS) Market Unbeaten over 2025
Next-generation Sequencing (NGS) Market: Snapshot Next Generation Sequencing (NGS) is utilized to execute different applications, for instance, biomarker revelation, oncology thinks about, customized solution, rural and creature research, and others. NGS has streamlined nucleotide investigation and has broadly supplanted customary instruments of genomics, particularly microarray effectively. The interest for NGS has expanded altogether inferable from surge in NGS applications and ascend in mechanical progressions in NGS. What's more, the development in
Next Generation Sequencing (NGS) Data Analysis Market Trepidation In 2025
Next Generation Sequencing (NGS) Data Analysis Market: Snapshot NGS is the term which is used to describe a number of different modern sequencing technologies and is also known as high throughput sequencing. Researchers are allowed to examine the biological systems, deeply due to exceptional throughput, scalability of systems, and speed by the next generation sequencing (NGS). In present times, a greater level of understanding is demanded due to the complexities involved
Global Next Generation Sequencing (NGS) Market Is driven by Increased in adoptio …
The Global Next-Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for
Next Generation Sequencing (NGS) at a CAGR of 23.59%
The Asia-Pacific NGS market which was worth $ 567.7 million in 2016 is poised to reach $1,636.7 million by 2021 at a CAGR of 23.59%. Asia presents significant opportunities for the investors/venture capitalists as the developed markets are saturated. The presence of noteworthy developments by China and Japan for integration of new technologies and the development of healthcare is majorly driving the Asia Pacific Market. Sample Report Request: R&D and